Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:57 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant

ClinicalTrials.gov · NCT02986204 · Registry updated: 2021-04-30

Condition / research focus: Women With an ENG Contraceptive Implant
Sponsor: University of California, Los Angeles
Countries with listed sites: United States
Registry dates and results: Start: 2017-01. Completion: 2020-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

removal of ENG implant (procedure)
continuation of ING implant (procedure)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

UCLA Dept. OB/GYN, Women's Health CRU, 10833 Le Conte Ave, CHS 22-265
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment

ClinicalTrials.gov · NCT02748278 · Registry updated: 2021-04-29

Condition / research focus: Subfertility
Sponsor: The University of Hong Kong
Countries with listed sites: China
Registry dates and results: Start: 2016-10-01. Completion: 2020-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transvaginal ultrasound-guided oocyte retrieval (procedure)
Embryo transfer (procedure)

Where the study takes place — 1 listed sites

Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Study of the Reproducibility of Laser Measurement in the Detection of Digital Obstructive Arterial Disease (DOAD)

ClinicalTrials.gov · NCT03264820 · Registry updated: 2021-04-15

Condition / research focus: Vascular Diseases
Sponsor: Rennes University Hospital
Countries with listed sites: France
Registry dates and results: Start: 2017-12-06. Completion: 2019-04-10 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Laser Doppler (device)
Laser speckle (device)
pain evaluation (behavioral)
Blood pressure and heart rate (other)

Where the study takes place — 1 listed sites

CHU Rennes _ Service de radiologie et imagerie médicale
Rennes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of Changes in Fluid Status on Right Ventricular Volumes and Function

ClinicalTrials.gov · NCT02967315 · Registry updated: 2021-04-14

Condition / research focus: Tetralogy of Fallot
Sponsor: University of Wisconsin, Madison
Countries with listed sites: United States
Registry dates and results: Start: 2014-06-06. Completion: 2021-03-18 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cardiac Magnetic Resonance Imaging (CMRI) (procedure)
Central venous line placement (procedure)
Chest X-ray (procedure)
Fluid administration (procedure)
Blood Draw (procedure)
Pregnancy test (procedure)
Electrocardiogram (procedure)

Where the study takes place — 1 listed sites

University of Wisconsin-Madison
Madison, Wisconsin, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

ClinicalTrials.gov · NCT04797338 · Registry updated: 2021-04-01

Condition / research focus: Pregnancy Early; Miscarriage; Ovarian Hyperstimulation Syndrome
Sponsor: Assaf-Harofeh Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2017-12-29. Completion: 2021-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Synarel, 0.2 Mg/Inh Nasal Spray (drug) — also listed as: Nafarelin
Estrofem (drug) — also listed as: Progynova
Utrogestan (drug) — also listed as: Endometrin
Hydroxyprogesterone Caproate (drug) — also listed as: Proluton Depot

Where the study takes place — 1 listed sites

Shamir Medical center
Be’er Ya‘aqov, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART

ClinicalTrials.gov · NCT03423537 · Registry updated: 2021-03-30

Condition / research focus: HCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin
Sponsor: National and Kapodistrian University of Athens
Countries with listed sites: Greece
Registry dates and results: Start: 2018-06-01. Completion: 2019-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl
Placebo (drug)

Where the study takes place — 1 listed sites

3rd Department of Obstetrics and Gynecology, Assisted Reproduction Unit
Athens, Chaidari, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF

ClinicalTrials.gov · NCT01058252 · Registry updated: 2021-03-24

Condition / research focus: Primary Infertility; Secondary Infertility; Low Responders; Mild to Moderate Male Factor Infertility
Sponsor: Galaxy Pharma (Pvt) Limited
Countries with listed sites: Pakistan
Registry dates and results: Start: 2021-05. Completion: 2022-03 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

INVOCell, Letrozole 2.5 mg, recFSH 75 IU (combination_product) — also listed as: Aromek (Letrozole 2.5 mg);, Follitrope (Recombinent FSH - 75 IU), IVF-C 5000 IU (HCG), Ova-Surge (Urinary LH Surge Kit), Indomethacin 50 mg
STEP-3: LH Suppression & Monitoring (procedure)
STEP-4: HCG Timing (procedure) — also listed as: IVF-C 5000 IU
STEP-5: OPU, ET, Cancellation (procedure) — also listed as: Ovum Pick-Up, Embryo Transfer, Ultrasound Guided
INVOCell (Intravaginal Culturing) (procedure) — also listed as: INVOCell, Diaphragm (Retention Device)

Where the study takes place — 2 listed sites

Lady Wallington Hospital
Lahore, Punjab Province, Pakistan
Site recruitment: Recruiting
Ova IVF & Reproductive Health Clinics
Karachi, Sindh, Pakistan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

ClinicalTrials.gov · NCT01319695 · Registry updated: 2021-03-17

Condition / research focus: Infertility
Sponsor: National and Kapodistrian University of Athens
Countries with listed sites: Greece
Registry dates and results: Start: 2011-01. Completion: 2017-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

corifollitropin alfa (drug)
recombinant follicle stimulating hormone (FSH) (drug)

Where the study takes place — 2 listed sites

3rd Department of Obstetrics and Gynecology, Assisted Reproduction Unit
Athens, Chaidari, Greece
Site recruitment: Not reported
Attikon University Hospital
Athens, Chaidari, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation

ClinicalTrials.gov · NCT03735030 · Registry updated: 2021-03-11

Condition / research focus: Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Switzerland
Registry dates and results: Start: 2018-11-27. Completion: 2019-08-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human hCG 10'000 IU (drug)
Recombinant hCG 6'500 IU (drug)

Where the study takes place — 1 listed sites

CROSS Research SA
Arzo, Canton Ticino, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes

ClinicalTrials.gov · NCT04454749 · Registry updated: 2021-03-08

Condition / research focus: Endometrial Disorder; Infertility, Female; IVF; Pregnancy Early
Sponsor: ART Fertility Clinics LLC
Countries with listed sites: United Arab Emirates
Registry dates and results: Start: 2020-11-09. Completion: 2021-03-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood test (diagnostic_test)
Ultrasound (diagnostic_test)

Where the study takes place — 1 listed sites

IVI Middle East Fertility Clinic
Abu Dhabi, United Arab Emirates
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Stools and Life Habits Collection in Heathy Volunteers/Subjects - to Provide Material for in Vitro Model Development

ClinicalTrials.gov · NCT04301973 · Registry updated: 2021-03-02

Condition / research focus: Healthy Subjects
Sponsor: Danone Global Research & Innovation Center
Countries with listed sites: France
Registry dates and results: Start: 2020-09-02. Completion: 2021-01-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Stool collection (other)

Where the study takes place — 1 listed sites

Biofortis
Saint-Herblain, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Fresh Versus Freeze-only After CAPA IVM on PCOS Patients

ClinicalTrials.gov · NCT04297553 · Registry updated: 2021-02-24

Condition / research focus: PCOS; IVM; Embryo Transfer
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2020-03-06. Completion: 2020-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CAPA-Fresh (procedure)
CAPA-Freeze-only (procedure)

Where the study takes place — 1 listed sites

Mỹ Đức Hospital
Ho Chi Minh City, Tan Binh, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Progesterone Versus Progesterone Plus Dydrogesterone in FET

ClinicalTrials.gov · NCT03998761 · Registry updated: 2021-02-24

Condition / research focus: Infertility
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2019-06-26. Completion: 2021-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Micronized Progesterone (drug) — also listed as: Cyclogest 400mg
Micronized progesterone plus dydrogesterone (drug) — also listed as: Cyclogest 400 mg + Duphaston 10 mg

Where the study takes place — 1 listed sites

Mỹ Đức Hospital
Ho Chi Minh City, Tan Binh, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Correlation Between Oocyte and Embryo Mechanical Properties on Embryo Development and Clinical Pregnancy After In Vitro Fertilization

ClinicalTrials.gov · NCT02530892 · Registry updated: 2021-02-16

Condition / research focus: Infertility; Pregnancy, Multiple
Sponsor: Stanford University
Countries with listed sites: China · Taiwan · United States
Registry dates and results: Start: 2015-08. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

EmbryoHug (procedure) — also listed as: Micropipette Aspiration, Mechanical Measurement

Where the study takes place — 3 listed sites

Stanford University IVF clinic
Stanford, California, United States
Site recruitment: Not reported
Shenzhen Army and Police Hospital--Reproductive Unit
Shenzhen, China
Site recruitment: Not reported
Taiwan IVF Group
Hsinchu, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin

ClinicalTrials.gov · NCT04749979 · Registry updated: 2021-02-11

Condition / research focus: Infertility
Sponsor: Aljazeera Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-02-05. Completion: 2021-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Agonist (decapeptyl ) (drug)
HCG ( eg. Choriomon ) (drug)

Where the study takes place — 1 listed sites

Aljazeera( Al Gazeera) hospital
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Home Pregnancy Test Evaluation, Lay User Study

ClinicalTrials.gov · NCT04372745 · Registry updated: 2021-02-09

Condition / research focus: Pregnancy Related
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2020-10-08. Completion: 2020-11-04 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics

ClinicalTrials.gov · NCT04744519 · Registry updated: 2021-02-09

Condition / research focus: hCG
Sponsor: IVI Vigo
Countries with listed sites: Spain
Registry dates and results: Start: 2019-01-20. Completion: 2019-06-25 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Collect data (other) — also listed as: Collect retrospectively data on embryo implantation rate

Where the study takes place — 1 listed sites

IVI Vigo
Vigo, Pontevedra, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Pilot Study: hCG Secreted by Blastocyst as Potential Marker of Embryo Quality

ClinicalTrials.gov · NCT04736160 · Registry updated: 2021-02-04

Condition / research focus: Embryo Disorder
Sponsor: IVI Vigo
Countries with listed sites: Spain
Registry dates and results: Start: 2018-12-05. Completion: 2021-11-25 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

collect data (other)

Where the study takes place — 1 listed sites

IVI Vigo
Vigo, Pontevedra, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG

ClinicalTrials.gov · NCT03208972 · Registry updated: 2021-02-03

Condition / research focus: Infertility
Sponsor: AZ Jan Palfijn Gent
Countries with listed sites: Belgium
Registry dates and results: Start: 2014-10. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

low dose hCG (drug) — also listed as: Pregnyl
hp-FSH (drug) — also listed as: Menopur
Corifollitropin Alfa (drug) — also listed as: Elonva

Where the study takes place — 1 listed sites

AZ Jan Palfijn
Ghent, Oost-Vlaanderen, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients

ClinicalTrials.gov · NCT01683513 · Registry updated: 2021-02-02

Condition / research focus: Infertility; PCOS
Sponsor: AZ Jan Palfijn Gent
Countries with listed sites: Belgium
Registry dates and results: Start: 2011-11. Completion: 2015-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRh agonist +1500E hCG (drug)

Where the study takes place — 1 listed sites

AZ Jan Palfijn
Ghent, Oost-vlaanderen, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:57 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

Identification and Removal of the Non Palpable Etonogestrel Contraceptive Implant

ClinicalTrials.gov · NCT02986204 · Registry updated: 2021-04-30

Condition / research focus: Women With an ENG Contraceptive Implant
Sponsor: University of California, Los Angeles
Countries with listed sites: United States
Registry dates and results: Start: 2017-01. Completion: 2020-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

removal of ENG implant (procedure)
continuation of ING implant (procedure)

Where the study takes place — 1 listed sites

UCLA Dept. OB/GYN, Women's Health CRU, 10833 Le Conte Ave, CHS 22-265
Los Angeles, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment

ClinicalTrials.gov · NCT02748278 · Registry updated: 2021-04-29

Condition / research focus: Subfertility
Sponsor: The University of Hong Kong
Countries with listed sites: China
Registry dates and results: Start: 2016-10-01. Completion: 2020-12-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transvaginal ultrasound-guided oocyte retrieval (procedure)
Embryo transfer (procedure)

Where the study takes place — 1 listed sites

Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Study of the Reproducibility of Laser Measurement in the Detection of Digital Obstructive Arterial Disease (DOAD)

ClinicalTrials.gov · NCT03264820 · Registry updated: 2021-04-15

Condition / research focus: Vascular Diseases
Sponsor: Rennes University Hospital
Countries with listed sites: France
Registry dates and results: Start: 2017-12-06. Completion: 2019-04-10 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Laser Doppler (device)
Laser speckle (device)
pain evaluation (behavioral)
Blood pressure and heart rate (other)

Where the study takes place — 1 listed sites

CHU Rennes _ Service de radiologie et imagerie médicale
Rennes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of Changes in Fluid Status on Right Ventricular Volumes and Function

ClinicalTrials.gov · NCT02967315 · Registry updated: 2021-04-14

Condition / research focus: Tetralogy of Fallot
Sponsor: University of Wisconsin, Madison
Countries with listed sites: United States
Registry dates and results: Start: 2014-06-06. Completion: 2021-03-18 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cardiac Magnetic Resonance Imaging (CMRI) (procedure)
Central venous line placement (procedure)
Chest X-ray (procedure)
Fluid administration (procedure)
Blood Draw (procedure)
Pregnancy test (procedure)
Electrocardiogram (procedure)

Where the study takes place — 1 listed sites

University of Wisconsin-Madison
Madison, Wisconsin, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

ClinicalTrials.gov · NCT04797338 · Registry updated: 2021-04-01

Condition / research focus: Pregnancy Early; Miscarriage; Ovarian Hyperstimulation Syndrome
Sponsor: Assaf-Harofeh Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2017-12-29. Completion: 2021-09-30 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Synarel, 0.2 Mg/Inh Nasal Spray (drug) — also listed as: Nafarelin
Estrofem (drug) — also listed as: Progynova
Utrogestan (drug) — also listed as: Endometrin
Hydroxyprogesterone Caproate (drug) — also listed as: Proluton Depot

Where the study takes place — 1 listed sites

Shamir Medical center
Be’er Ya‘aqov, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Low-dose HCG as an Adjunct to Ovarian Stimulation in Subfertile Women Undergoing ART

ClinicalTrials.gov · NCT03423537 · Registry updated: 2021-03-30

Condition / research focus: HCG; IVF; Pregnancy Rates; ART; Chorionic Gonadotropin
Sponsor: National and Kapodistrian University of Athens
Countries with listed sites: Greece
Registry dates and results: Start: 2018-06-01. Completion: 2019-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug) — also listed as: Pregnyl
Placebo (drug)

Where the study takes place — 1 listed sites

3rd Department of Obstetrics and Gynecology, Assisted Reproduction Unit
Athens, Chaidari, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF

ClinicalTrials.gov · NCT01058252 · Registry updated: 2021-03-24

Condition / research focus: Primary Infertility; Secondary Infertility; Low Responders; Mild to Moderate Male Factor Infertility
Sponsor: Galaxy Pharma (Pvt) Limited
Countries with listed sites: Pakistan
Registry dates and results: Start: 2021-05. Completion: 2022-03 (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

INVOCell, Letrozole 2.5 mg, recFSH 75 IU (combination_product) — also listed as: Aromek (Letrozole 2.5 mg);, Follitrope (Recombinent FSH - 75 IU), IVF-C 5000 IU (HCG), Ova-Surge (Urinary LH Surge Kit), Indomethacin 50 mg
STEP-3: LH Suppression & Monitoring (procedure)
STEP-4: HCG Timing (procedure) — also listed as: IVF-C 5000 IU
STEP-5: OPU, ET, Cancellation (procedure) — also listed as: Ovum Pick-Up, Embryo Transfer, Ultrasound Guided
INVOCell (Intravaginal Culturing) (procedure) — also listed as: INVOCell, Diaphragm (Retention Device)

Where the study takes place — 2 listed sites

Lady Wallington Hospital
Lahore, Punjab Province, Pakistan
Site recruitment: Recruiting
Ova IVF & Reproductive Health Clinics
Karachi, Sindh, Pakistan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

ClinicalTrials.gov · NCT01319695 · Registry updated: 2021-03-17

Condition / research focus: Infertility
Sponsor: National and Kapodistrian University of Athens
Countries with listed sites: Greece
Registry dates and results: Start: 2011-01. Completion: 2017-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

corifollitropin alfa (drug)
recombinant follicle stimulating hormone (FSH) (drug)

Where the study takes place — 2 listed sites

3rd Department of Obstetrics and Gynecology, Assisted Reproduction Unit
Athens, Chaidari, Greece
Site recruitment: Not reported
Attikon University Hospital
Athens, Chaidari, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation

ClinicalTrials.gov · NCT03735030 · Registry updated: 2021-03-11

Condition / research focus: Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Switzerland
Registry dates and results: Start: 2018-11-27. Completion: 2019-08-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human hCG 10'000 IU (drug)
Recombinant hCG 6'500 IU (drug)

Where the study takes place — 1 listed sites

CROSS Research SA
Arzo, Canton Ticino, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes

ClinicalTrials.gov · NCT04454749 · Registry updated: 2021-03-08

Condition / research focus: Endometrial Disorder; Infertility, Female; IVF; Pregnancy Early
Sponsor: ART Fertility Clinics LLC
Countries with listed sites: United Arab Emirates
Registry dates and results: Start: 2020-11-09. Completion: 2021-03-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood test (diagnostic_test)
Ultrasound (diagnostic_test)

Where the study takes place — 1 listed sites

IVI Middle East Fertility Clinic
Abu Dhabi, United Arab Emirates
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Stools and Life Habits Collection in Heathy Volunteers/Subjects - to Provide Material for in Vitro Model Development

ClinicalTrials.gov · NCT04301973 · Registry updated: 2021-03-02

Condition / research focus: Healthy Subjects
Sponsor: Danone Global Research & Innovation Center
Countries with listed sites: France
Registry dates and results: Start: 2020-09-02. Completion: 2021-01-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Stool collection (other)

Where the study takes place — 1 listed sites

Biofortis
Saint-Herblain, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Fresh Versus Freeze-only After CAPA IVM on PCOS Patients

ClinicalTrials.gov · NCT04297553 · Registry updated: 2021-02-24

Condition / research focus: PCOS; IVM; Embryo Transfer
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2020-03-06. Completion: 2020-12-15 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

CAPA-Fresh (procedure)
CAPA-Freeze-only (procedure)

Where the study takes place — 1 listed sites

Mỹ Đức Hospital
Ho Chi Minh City, Tan Binh, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Progesterone Versus Progesterone Plus Dydrogesterone in FET

ClinicalTrials.gov · NCT03998761 · Registry updated: 2021-02-24

Condition / research focus: Infertility
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2019-06-26. Completion: 2021-01-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Micronized Progesterone (drug) — also listed as: Cyclogest 400mg
Micronized progesterone plus dydrogesterone (drug) — also listed as: Cyclogest 400 mg + Duphaston 10 mg

Where the study takes place — 1 listed sites

Mỹ Đức Hospital
Ho Chi Minh City, Tan Binh, Vietnam
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Correlation Between Oocyte and Embryo Mechanical Properties on Embryo Development and Clinical Pregnancy After In Vitro Fertilization

ClinicalTrials.gov · NCT02530892 · Registry updated: 2021-02-16

Condition / research focus: Infertility; Pregnancy, Multiple
Sponsor: Stanford University
Countries with listed sites: China · Taiwan · United States
Registry dates and results: Start: 2015-08. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

EmbryoHug (procedure) — also listed as: Micropipette Aspiration, Mechanical Measurement

Where the study takes place — 3 listed sites

Stanford University IVF clinic
Stanford, California, United States
Site recruitment: Not reported
Shenzhen Army and Police Hospital--Reproductive Unit
Shenzhen, China
Site recruitment: Not reported
Taiwan IVF Group
Hsinchu, Taiwan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin

ClinicalTrials.gov · NCT04749979 · Registry updated: 2021-02-11

Condition / research focus: Infertility
Sponsor: Aljazeera Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2021-02-05. Completion: 2021-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Agonist (decapeptyl ) (drug)
HCG ( eg. Choriomon ) (drug)

Where the study takes place — 1 listed sites

Aljazeera( Al Gazeera) hospital
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Home Pregnancy Test Evaluation, Lay User Study

ClinicalTrials.gov · NCT04372745 · Registry updated: 2021-02-09

Condition / research focus: Pregnancy Related
Sponsor: SPD Development Company Limited
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2020-10-08. Completion: 2020-11-04 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics

ClinicalTrials.gov · NCT04744519 · Registry updated: 2021-02-09

Condition / research focus: hCG
Sponsor: IVI Vigo
Countries with listed sites: Spain
Registry dates and results: Start: 2019-01-20. Completion: 2019-06-25 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Collect data (other) — also listed as: Collect retrospectively data on embryo implantation rate

Where the study takes place — 1 listed sites

IVI Vigo
Vigo, Pontevedra, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Pilot Study: hCG Secreted by Blastocyst as Potential Marker of Embryo Quality

ClinicalTrials.gov · NCT04736160 · Registry updated: 2021-02-04

Condition / research focus: Embryo Disorder
Sponsor: IVI Vigo
Countries with listed sites: Spain
Registry dates and results: Start: 2018-12-05. Completion: 2021-11-25 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

collect data (other)

Where the study takes place — 1 listed sites

IVI Vigo
Vigo, Pontevedra, Spain
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG

ClinicalTrials.gov · NCT03208972 · Registry updated: 2021-02-03

Condition / research focus: Infertility
Sponsor: AZ Jan Palfijn Gent
Countries with listed sites: Belgium
Registry dates and results: Start: 2014-10. Completion: 2015-11 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

low dose hCG (drug) — also listed as: Pregnyl
hp-FSH (drug) — also listed as: Menopur
Corifollitropin Alfa (drug) — also listed as: Elonva

Where the study takes place — 1 listed sites

AZ Jan Palfijn
Ghent, Oost-Vlaanderen, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Trial Comparing hCG Triggering Versus GnRH Agonist Triggering in PCOS Patients

ClinicalTrials.gov · NCT01683513 · Registry updated: 2021-02-02

Condition / research focus: Infertility; PCOS
Sponsor: AZ Jan Palfijn Gent
Countries with listed sites: Belgium
Registry dates and results: Start: 2011-11. Completion: 2015-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRh agonist +1500E hCG (drug)

Where the study takes place — 1 listed sites

AZ Jan Palfijn
Ghent, Oost-vlaanderen, Belgium
Site recruitment: Not reported

Original record, eligibility, contacts and results →